Analysed OCULAR THERAPEUTIX INC (OCUL:NASDAQ) News Sources
Is Ocular Therapeutix (OCUL) Quietly Recasting Its Retinal Strategy Around Axpaxli’s Phase 3 Design Choices?
13-04-2026
yahoo.com
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
13-04-2026
yahoo.com
Assessing Whether Ocular Therapeutix (OCUL) Looks Undervalued After Recent Mixed Share Price Performance
12-04-2026
yahoo.com
Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
01-04-2026
yahoo.com
What Ocular Therapeutix (OCUL)'s Single-Study FDA Bid After SOL-1 Superiority Means For Shareholders
27-03-2026
yahoo.com
Ocular Therapeutix Touts Landmark Phase 3 AXPAXLI Win at RBC Ophthalmology Conference
26-03-2026
marketbeat.com
What is the current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is $8.79.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is $-0.51.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is -5.4839%.
What is the most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is .
SEC-8K** Filing Available For OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.